New combo attack on deadly brain cancer
Disease control
Recruiting now
This study is testing a two-part treatment for people whose aggressive brain cancer (glioblastoma) has come back. It combines a drug that helps the immune system fight cancer with a very precise form of radiation, given before planned surgery. The main goals are to see if this co…
Phase: PHASE1, PHASE2 • Sponsor: Chirag G. Patil • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC